Sign in
Not yet recruitingPhase 3

Early Corticosteroids in Severe Influenza Pneumonia, a phase III randomized controlled trial

Key facts

Who runs it
Centre Hospital Region Metz Thionville
Where
France51 sites in 1 countryChoose a country to see its sites
Status
Not yet recruiting
Phase
Phase 3
People taking part
544 people, planned
Started
1 Oct 2026
Expected to end
1 Jan 2030
Type of study
Interventional
Record updated
9 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Admission to ICU or intermediate care for less than 2 days
  • Admission to hospital for less than 5 days
  • Diagnosis of influenza pneumonia with • PCR positive for Influenza dated less than 5 days • AND focal shadowing/infiltrates on chest X-ray or CT-scan • AND at least one of the following: cough, purulent sputum, chest pain or dyspnoea
  • Requirement of supplemental oxygen at a flow rate of at least 3 L/min OR non-invasive ventilation OR high flow oxygen therapy OR invasive mechanical ventilation
  • Written informed or emergency consent
  • Ongoing medical insurance

Who cannot take part

  • Subject with shock on enrolment and on ongoing vasopressor therapy (≥ 0.25 microg/kg/min)
  • Indication for corticosteroid therapy in a dosage above 0.5 mg/kg/day prednisone-equivalent
  • Bone marrow transplant or chemotherapy-induced neutropenia
  • Known allergy to dexamethasone or to one of its excipients
  • Co-infection with COVID-19
  • Known active tuberculosis or fungal infection
  • Active viral hepatitis or active herpes virus infection
  • Moribund state
  • Patient at risk of strongyloidiasis
  • Subject deprived of liberty or under a legal protective measure (example: patients under guardianship or curatorship)
  • Pregnant or breastfeeding woman
  • Lack of clinical equipoise by the attending physician and/or the presence of a substantial risk associated with the patients’ participation in the trial
  • Uncontrolled psychotic states
  • Pheochromocytoma
  • Cardiogenic shock secondary to influenza myocarditis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To compare the efficacy of dexamethasone versus placebo in patients with severe influenza on a hierarchical composite endpoint of all-cause mortality, number of ventilator-free days and number of ICU-free days between day 0 and day 28.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
ECSIP : Early Corticosteroids in Severe Influenza Pneumonia, a phase III randomized controlled trial
Record updated
9 October 2026